Alex Knapp, Forbes Staff

Author's posts

Lab Study Suggests Pfizer/BioNTech Vaccine Effective Against Variants After Second Dose

The lab study found a strong immune response to the U.K. and South African variants, with a ‘robust, but lower’ response to the South African variant.

Little-Known Publicly Traded Company Given Massive Deal To Manufacture One-Shot Covid-19 Vaccine

While Johnson & Johnson developed and got FDA authorization for its one-dose vaccine, it won’t be the one manufacturing it – that big task and huge windfall goes to a mostly unknown company in Maryland.

This Startup Just Raised $123 Million To Develop A New Way To Find Medicine

Cellarity aims to discover new therapies by looking at the impact of disease on the whole cell.

This College Professor Became An Overnight Billionaire Fighting Covid

Carl Hansen’s Abcellera Biologics scored big helping Eli Lilly develop antibodies to treat symptoms of Covid-19.

AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs

The Boston-based company aims to accelerate the drug discovery process for cancer therapies that are both more effective and less toxic.

Forbes Favorites 2020: The Year’s Best Non-Pandemic Healthcare Stories

Although Covid-19 dominated the discussion, there was a lot more happening in the healthcare industry in 2020. Here are six of the best stories of the year.

Forbes Favorites 2020: The Year’s Best Covid-19 Healthcare Stories

From the frontlines of the pandemic to the companies producing the first vaccines, here are seven of the best stories about the fight against Covid-19.

FDA Review Of Pfizer Vaccine Data Confirms Protection Against Covid-19 Infection

The positive data will inform the regulatory body’s discussion over whether to authorize use of the vaccine, which could happen as early as Thursday.

Here’s What You Need To Know About AstraZeneca’s Covid-19 Vaccine

AstraZeneca, with partner Oxford University, released preliminary data for its phase 3 Covid-19 Monday showing that the vaccine may be up to 90% effective.

What You Need To Know About Moderna’s Covid-19 Vaccine

The Boston-based biotech firm is neck and neck with Pfizer in the race to have the first Covid-19 vaccine authorized for use.